Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model

PLoS One. 2013 Apr 18;8(4):e61923. doi: 10.1371/journal.pone.0061923. Print 2013.

Abstract

Aims: In collateral development (i.e. arteriogenesis), mononuclear cells are important and exist as a heterogeneous population consisting of pro-inflammatory and anti-inflammatory/repair-associated cells. Protease-activated receptor (PAR)1 and PAR2 are G-protein-coupled receptors that are both expressed by mononuclear cells and are involved in pro-inflammatory reactions, while PAR2 also plays a role in repair-associated responses. Here, we investigated the physiological role of PAR1 and PAR2 in arteriogenesis in a murine hind limb ischemia model.

Methods and results: PAR1-deficient (PAR1-/-), PAR2-deficient (PAR2-/-) and wild-type (WT) mice underwent femoral artery ligation. Laser Doppler measurements revealed reduced post-ischemic blood flow recovery in PAR2-/- hind limbs when compared to WT, while PAR1-/- mice were not affected. Upon ischemia, reduced numbers of smooth muscle actin (SMA)-positive collaterals and CD31-positive capillaries were found in PAR2-/- mice when compared to WT mice, whereas these parameters in PAR1-/- mice did not differ from WT mice. The pool of circulating repair-associated (Ly6C-low) monocytes and the number of repair-associated (CD206-positive) macrophages surrounding collaterals in the hind limbs were increased in WT and PAR1-/- mice, but unaffected in PAR2-/- mice. The number of repair-associated macrophages in PAR2-/- hind limbs correlated with CD11b- and CD115-expression on the circulating monocytes in these animals, suggesting that monocyte extravasation and M-CSF-dependent differentiation into repair-associated cells are hampered.

Conclusion: PAR2, but not PAR1, is involved in arteriogenesis and promotes the repair-associated response in ischemic tissues. Therefore, PAR2 potentially forms a new pro-arteriogenic target in coronary artery disease (CAD) patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arterioles / physiology
  • Cell Differentiation
  • Collateral Circulation / physiology*
  • Disease Models, Animal
  • Femoral Artery
  • Hindlimb / blood supply*
  • Ischemia
  • Lectins, C-Type / immunology
  • Ligation
  • Macrophages / cytology
  • Macrophages / immunology
  • Male
  • Mannose Receptor
  • Mannose-Binding Lectins / immunology
  • Mice
  • Monocytes / physiology*
  • Receptor, PAR-1 / deficiency
  • Receptor, PAR-1 / physiology*
  • Receptor, PAR-2 / physiology*
  • Receptors, Cell Surface / immunology

Substances

  • Lectins, C-Type
  • Mannose Receptor
  • Mannose-Binding Lectins
  • Receptor, PAR-1
  • Receptor, PAR-2
  • Receptors, Cell Surface

Grants and funding

This work was supported by the Smart-Mix Translational excellence in Regenerative Medicine (TeRM) program to A.A.H.; the Kassenaar Fund and the Leducq Initiative Against Thrombosis (LINAT) [0630/09/KB to H.H.V.]. H.H.V. is the recipient of a NWO VIDI award (17.106.329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.